2018 Pan Pacific Lymphoma Conference
C

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
49 views
August 15, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
18:26
William Schaffner

Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…

10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
41:20
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…

Feat. N. Bartlett
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
15:18
UNC Lineberger Comprehensive Cancer Center

Hodgkin Lymphoma Management: Updates for 2023

Feat. N. Grover
40:13
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Feat. R. C. Lynch
30:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment of Older Patients With HL in the …

Feat. A. Evens
42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
28:57
Total Health

Highlights From Key Hematology Trials at ASCO® 2023

Feat. J. Strauss
15:24
Total Health

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

Feat. J. Svoboda
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
23:24
SOHO Brazil 2023

2023 SOHO® Brazil: "How I Sequence New Agents in First and Seco…

Feat. A. Moskowitz
08:02
ASH 2022 Conference Coverage

ASH 2022 Results From Phase III BMT CTN 1703: Post-Transplant Cyclop…

Feat. S. Holtan
10:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: HL

Feat. A. Herrera
08:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …

Feat. A. Mcdonald
15:56
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Management of Hodgkin Lymphoma

Feat. J. Svoboda
08:30
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic…

Feat. S. Desai
12:19
SOHO Brazil 2023

2023 SOHO® Brazil: "Are We About to Abandon Transplant in HL?&q…

Feat. A. Moskowitz
32:39
MyCancerHaven

Experts Discuss the Basics of Allogeneic Stem Cell Transplant

Feat. R. Vij, M. Christopher